Using RWE in rare disease drug development: effective innovations with historical controls
European Pharmaceutical Review
SEPTEMBER 22, 2022
The application of Bayesian methodology has been recognised by the US Food and Drug Administration (FDA) as useful in early phase clinical trials involving paediatric populations. Dr Maier has over 25 years of experience in drug development and commercialisation at pharmaceutical companies in Europe, Canada, the United States and Asia.
Let's personalize your content